UMP/CMPK Is Not the Critical Enzyme in the Metabolism of Pyrimidine Ribonucleotide and Activation of Deoxycytidine Analogs in Human RKO Cells
2011

The Role of UMP/CMP Kinase in Nucleotide Metabolism

publication Evidence: moderate

Author Information

Author(s): Hu Rong, Lam Wing, Hsu Chih-Hung, Cheng Yung-Chi

Primary Institution: Yale University School of Medicine

Hypothesis

Does UMP/CMP kinase play a critical role in the metabolism of pyrimidine ribonucleotides and the activation of deoxycytidine analogs in human cells?

Conclusion

UMP/CMP kinase is not critical for the phosphorylation of CMP and dCMP or for the activation of deoxycytidine analogs in RKO cells.

Supporting Evidence

  • The study showed that altering UMP/CMP kinase levels by 500% or 95-98% did not change the levels of pyrimidine nucleotides in cells.
  • Metabolism of deoxycytidine analogs was unaffected by changes in UMP/CMP kinase expression.
  • Cell growth inhibition assays indicated that UMP/CMP kinase levels did not influence the effectiveness of certain cancer drugs.

Takeaway

This study found that changing the amount of a specific enzyme, UMP/CMP kinase, in cells doesn't affect how the cells use certain important building blocks for DNA and RNA.

Methodology

Two stable RKO cell lines were created to either up-regulate or down-regulate UMP/CMP kinase expression, and the effects on nucleotide metabolism were analyzed.

Limitations

The study may not account for compensatory mechanisms in nucleotide metabolism that could mask the effects of UMP/CMP kinase.

Digital Object Identifier (DOI)

10.1371/journal.pone.0019490

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication